Presentation THT Abstracts 2025 Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy Presenter: Ahmed Mahmoud February 11, 2025 REGISTER for free or LOG IN to view this content Heart Failure THT Abstracts 2025 Up Next Presentation THT Abstracts 2025 Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study Presenter: Thitiphan Srikulmontri February 11, 2025 More slides + Presentation THT Abstracts 2025 Navigating Conduction Abnormalities Following Transcatheter Tricuspid Valve Replacement (TTVR): A Single Center Experience Presenter: Tooba Salar February 11, 2025 Presentation THT Abstracts 2025 Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF) Presenter: Jonathan Zawadzki February 11, 2025 We Recommend
Presentation THT Abstracts 2025 Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study Presenter: Thitiphan Srikulmontri February 11, 2025
Presentation THT Abstracts 2025 Navigating Conduction Abnormalities Following Transcatheter Tricuspid Valve Replacement (TTVR): A Single Center Experience Presenter: Tooba Salar February 11, 2025
Presentation THT Abstracts 2025 Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF) Presenter: Jonathan Zawadzki February 11, 2025